in partnership with
What's the Plan?
We Know What COVID did to the Private Practice Industry - Now What?
LUNCH & LEARN
How to Fund Your Healthcare Practice During
Unprecedented Times and Beyond.
Friday, April 16, 2021
1:00-1:30 PM EDT
Restaurants and retailers aren’t the only small businesses that have taken a financial hit during the COVID-19 pandemic.
Physicians in small private practices, and home health care services around the country have reported steep declines in revenues, drops so significant that some of them and their supporters have turned crowdfunding to raise funds to help pay their overhead. Tele-medicine has helped pick up only a small portion of the slack.
As the healthcare industry continues to expand, cash flow from healthcare provider payments can be unpredictable and inconsistent. Insurance carrier turn around can take 90 days or longer to issue payment, making it more difficult to manage your cash flow, operate your business efficiently, deal with growth and any unexpected issues that may arise.
Cash Flow Solutions for Healthcare Providers
Medical accounts receivables financing is an asset-based factoring facility that fast-tracks payments from insurance carriers by allowing our partners to purchase your net eligible insurance receivables. The healthcare sector is stressed with cash flow issues due to outstanding insurance claims with terms between 30, 60, 90, 120 plus days.
Through our financial management solutions partners, healthcare providers can factor medical insurance account receivables for business growth and continue to deliver quality care.
YOU'RE STILL ON THE FRONT LINE
LET US HELP YOU
HELP YOUR PRACTICE
Join us on Wednesday, April 16th for a 30-minute Lunch & Learn session for information about how we can help you fund your healthcare practice and continue to serve your community.
this event is sponsored by
Vollara's air products are equipped with the exclusive, award-winning ActivePure Technology that safely eliminates nearly 100% of airborne and surface bacteria, viruses, mold, fungus + VOCs. ActivePure Technology confirms that the product kills the SARS-CoV-2 virus on surfaces. The testing data conducted by independent FDA-compliant laboratory, MRIGlobal, established a 99.98% surface kill rate of live SARS-CoV-2 virus in seven hours. SARS-CoV-2 is the virus that causes COVID-19.
ActivePure is designed to quietly work 24/7 to safely and effectively improve the air quality of indoor spaces. Here are just some of the ways ActivePure can help your practice, employees and your family:
The most powerful air and surface puriﬁcation technology ever discovered.
Works 24/7 to protect from airborne plus surface contaminants
Improves health plus quality of life
Destroys allergy plus asthma triggering particles
Purifies air and reduces odors
Protects from itchy eyes plus stuffy noses
Removes harmful gases
To learn more about Vollara for your home and practice click here